Phase I/II Dose-Finding, Safety, Tolerance, and Pharmacokinetics Study of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in HIV-Infected and TB Co-Infected Infants and Children
Phase of Trial: Phase I/II
Latest Information Update: 12 May 2017
At a glance
- Drugs Raltegravir (Primary) ; Antiretrovirals; Rifampicin
- Indications HIV-1 infections; Tuberculosis
- Focus Adverse reactions
- 08 May 2017 Planned number of patients changed from 72 to 108.
- 28 Jun 2016 Planned primary completion date changed from 1 May 2018 to 1 May 2019.
- 09 Jul 2015 Planned primary completion date changed from 1 May 2016 to 1 May 2018.